LeadCare Testing Systems (with Blood Obtained from a Vein) by Magellan Diagnostics: FDA Safety Communication - Risk of Inaccura
Date of publication: 06-06-2017
UPDATED 06/06/2017. Class I Recall expanded. Falsely lower test results may lead to improper patient management and treatment for lead exposure or poisoning. Źródło: https://www.fda.gov
